Post Marketing Surveillance on Long Term Drug Use of Trazenta Tablets as add-on Therapy in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2018
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 08 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 08 Nov 2017 Planned primary completion date changed from 1 Jun 2018 to 30 Sep 2018.